アフターアワーズ： 2.73 0.010 +0.37%

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA) 最新ニュース

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA) 最新ニュース

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Declines By 6.4% - MarketBeat

Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth By Investing.com - Investing.com South Africa

Wall Street SWOT: Akoya Biosciences stock faces headwinds amid spatial proteomics growth - Investing.com

Brokerages Set Akoya Biosciences, Inc. (NASDAQ:AKYA) Target Price at $6.56 - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Piper Sandler Maintains Akoya Biosciences (AKYA) Overweight Recommendation - MSN

Akoya Biosciences, Inc.'s (NASDAQ:AKYA) biggest owners are private equity firms who got richer after stock soared 18% last week - Simply Wall St

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 6.3% in August - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Europe, CIS & Africa Spatial Transcriptomics (Instruments, Consumables) Market Size, Share & Trends Analysis Report 2024-2030 - GlobeNewswire Inc.

Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Growth in Short Interest - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Large Increase in Short Interest - MarketBeat

Vanguard Group Inc. Has $6.82 Million Stock Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $4.00 at Piper Sandler - Defense World

Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $4.00 at Piper Sandler - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported, And Analysts Assigned A US$5.42 Price Target - Simply Wall St

FY2024 EPS Estimates for Akoya Biosciences, Inc. Raised by Capital One Financial (NASDAQ:AKYA) - MarketBeat

Capital One Financial Research Analysts Boost Earnings Estimates for Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World

Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint - Yahoo Finance

Closing Figures: Akoya Biosciences Inc (AKYA)’s Negative Finish at 2.01, Down -6.51 - The Dwinnex

Insiders Give Up US$52k As Akoya Biosciences Stock Drops To US$2.01 - Simply Wall St

JP Morgan Downgrades Akoya Biosciences (AKYA) - MSN

Akoya Biosciences (NASDAQ:AKYA) Price Target Lowered to $7.00 at Craig Hallum - Defense World

Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $7.00 by Analysts at Craig Hallum - MarketBeat

Akoya Biosciences (NASDAQ:AKYA) Releases Quarterly Earnings Results, Hits Expectations - MarketBeat

Morgan Stanley cuts Akoya Biosciences rating on capital spend concerns - Investing.com

Akoya Biosciences (NASDAQ:AKYA) Cut to “Equal Weight” at Morgan Stanley - Defense World

A Closer Look at 4 Analyst Recommendations For Akoya Biosciences - Benzinga

BTIG cuts Akoya Biosciences stock rating amid revenue, staff concerns By Investing.com - Investing.com Australia

Akoya Biosciences (NASDAQ:AKYA) Issues Quarterly Earnings Results - Defense World

JPMorgan Chase & Co. Lowers Akoya Biosciences (NASDAQ:AKYA) to Neutral - American Banking and Market News

Akoya Biosciences (NASDAQ:AKYA) Cut to "Equal Weight" at Morgan Stanley - MarketBeat

JPMorgan Chase & Co. Lowers Akoya Biosciences (NASDAQ:AKYA) to Neutral - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Akoya Biosciences sees revenue jump, aims for break-even - Investing.com Canada

BTIG cuts Akoya Biosciences stock rating amid revenue, staff concerns - Investing.com

Akoya: Q2 Earnings Snapshot - San Antonio Express-News

Akoya stock downgraded by JPMorgan after persistent macroeconomic pressures - Investing.com

Akoya Biosciences Reports Second Quarter 2024 Financial Results - ForexTV.com

Akoya: Q2 Earnings Snapshot - The Washington Post

Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript - Seeking Alpha

Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Akoya Biosciences Reports Second Quarter 2024 Financial Results - StockTitan

Akoya Biosciences Reports Second Quarter 2024 Financial Results - GlobeNewswire

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Silvercrest Asset Management Group LLC Makes New Investment in Akoya Biosciences, Inc. (NASDAQ:AKYA) - MarketBeat

Akoya Biosciences (AKYA) to Release Earnings on Monday - MarketBeat

Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World

Akoya Biosciences stock maintains $6 price target with Buy rating at BTIG - Investing.com

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Expands By 15.6% - American Banking and Market News

Akoya Biosciences to Report Second Quarter 2024 Financial - GlobeNewswire

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences - StockTitan

Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Growth in Short Interest - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 15.6% in June - Defense World

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences - Yahoo Finance

Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff - BioSpace

While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership - Yahoo Finance

Illumina boldly acquires Fluent Bio weeks after Grail divestiture - BioWorld Online

HR Tech Startup Remofirst Expands Management Team - GlobeNewswire Inc.

Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Average Rating of “Moderate Buy” by Analysts - Defense World

A closer look at Akoya Biosciences Inc (AKYA)’s stock price trends - US Post News

Metric Deep Dive: Understanding Akoya Biosciences Inc (AKYA) Through its Ratios - The Dwinnex

Talis Biomedical (NASDAQ:TLIS) & Akoya Biosciences (NASDAQ:AKYA) Financial Survey - Defense World

AKYAに似た銘柄